News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
260,741 Results
Type
Article (13565)
Company Profile (110)
Press Release (247066)
Section
Business (87937)
Career Advice (461)
Deals (15323)
Drug Delivery (63)
Drug Development (36521)
Employer Resources (49)
FDA (6259)
Job Trends (6182)
News (150008)
Policy (14006)
Tag
Academia (435)
Alliances (23074)
Alzheimer's disease (347)
Approvals (6250)
Artificial intelligence (58)
Bankruptcy (143)
Best Places to Work (4307)
Biosimilars (39)
Biotechnology (44)
Breast cancer (40)
Cancer (286)
Career advice (405)
Cell therapy (39)
Clinical research (30326)
Collaboration (129)
Compensation (55)
COVID-19 (746)
C-suite (49)
Data (290)
Diabetes (47)
Diagnostics (1230)
Drug pricing (56)
Earnings (31447)
Employer resources (43)
Events (36638)
Executive appointments (145)
FDA (6422)
Funding (91)
Gene therapy (58)
GLP-1 (287)
Government (1264)
Healthcare (3518)
Infectious disease (763)
Inflammatory bowel disease (45)
Interviews (58)
IPO (5808)
Job creations (2049)
Job search strategy (372)
Layoffs (166)
Legal (3409)
Lung cancer (44)
Manufacturing (85)
Medical device (1260)
Medtech (1262)
Mergers & acquisitions (9534)
Metabolic disorders (154)
Neuroscience (436)
NextGen Class of 2024 (1580)
Non-profit (589)
Northern California (388)
Obesity (96)
Opinion (108)
Patents (51)
People (28406)
Pharmaceutical (64)
Phase I (7886)
Phase II (12823)
Phase III (11526)
Pipeline (134)
Podcasts (39)
Policy (43)
Postmarket research (1399)
Preclinical (3161)
Radiopharmaceuticals (116)
Rare diseases (82)
Real estate (2629)
Regulatory (9801)
Research institute (562)
Resumes & cover letters (55)
Southern California (398)
Startups (1624)
United States (3905)
Vaccines (109)
Weight loss (76)
Date
Last 7 days (335)
Last 30 days (1021)
Last 365 days (12622)
2024 (11100)
2023 (14244)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14887)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (39)
Asia (19753)
Australia (2552)
California (907)
Canada (560)
China (100)
Connecticut (37)
Europe (38697)
Florida (130)
Illinois (102)
Indiana (81)
Kansas (51)
Maryland (146)
Massachusetts (802)
Minnesota (50)
New Jersey (384)
New York (251)
North Carolina (269)
Northern California (388)
Pennsylvania (265)
South America (498)
Southern California (398)
Texas (122)
Virginia (37)
Washington State (66)
260,741 Results for "edenbridge pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Edenbridge Pharmaceuticals Names Douglas S. Boothe as CEO
Edenbridge Pharmaceuticals, the U.S. subsidiary of Dexcel Pharma, announced that Douglas S. Boothe has been named Chief Executive Officer, effective January 1, 2024.
December 20, 2023
·
3 min read
Pharm Country
PANTHERx®Rare Selected by Edenbridge Pharmaceuticals as Specialty Pharmacy for Yargesa® (miglustat 100 mg capsules)
PANTHERx®Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Edenbridge Pharmaceuticals for the distribution of Yargesa® (miglustat) capsules, the first oral treatment option for adults with mild to moderate Type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option.
April 1, 2024
·
3 min read
Pharm Country
Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT
Edenbridge Pharmaceuticals, LLC (“Edenbridge”) today announced that DARTISLA ODT (glycopyrrolate) is now available by prescription in the United States through Phil, the commercialization partner and eHub for DARTISLA ODT, as well as in retail pharmacies throughout the country.
February 28, 2022
·
4 min read
FDA
Edenbridge Pharmaceuticals Announces U.S. FDA Approval of DARTISLA ODT (Glycopyrrolate) Orally Disintegrating Tablets
Edenbridge’s first 505(b)(2) branded drug to be granted FDA approval.
December 17, 2021
·
3 min read
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Press Releases
Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
October 28, 2024
·
9 min read
Press Releases
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
November 7, 2024
·
1 min read
BioMidwest
Aurorium Launches Haelium™ Pharmaceutical Solutions
Aurorium, a specialty ingredients manufacturer and materials innovation partner, is pleased to announce the launch of Haelium™ Pharmaceutical Solutions.
June 25, 2024
·
2 min read
Press Releases
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 6, 2024
·
20 min read
1 of 26,075
Next